Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • CORRESPONDENCE

Don't reject evidence from CFS therapies

  1. Michael Sharpe

    1. University of Oxford, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Trudie Chalder

    1. Guy’s, King’s and St Thomas’s School of Medicine, London, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. Jon Stone

    1. University of Edinburgh, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

We welcome your article on research into chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis or systemic exertion intolerance disease (see Nature 553, 14–17; 2018). In our view, however, you underestimate the benefits of current treatments: namely, graded exercise and cognitive behaviour therapy (CBT).

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 554, 31 (2018)

doi: https://doi.org/10.1038/d41586-018-01285-x

Competing Interests

M.S. has received royalties from academic writing. T.C. has received royalties from self-help books. J.S. has received royalties from academic writing and payments for acting as an independent medical expert.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links